✦ LIBER ✦
Clinical Trial Report: TMC278 (Rilpivirine) Versus Efavirenz as Initial Therapy in Treatment-Naïve, HIV-1–Infected Patients
✍ Scribed by Rodger D. MacArthur
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 75 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1523-3847
No coin nor oath required. For personal study only.